Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07805707 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

Name: A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age — clinical trial record (NCT07805707)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 3

SponsorGlaxoSmithKline

Started2026-09-02

View on ClinicalTrials.gov ↗

This study will compare an investigational mRNA flu vaccine with a licensed flu vaccine in adults 65 years of age and older. Participants will receive one injection and will be followed during the flu season. The study will measure prevention of laboratory-confirmed flu illness, side effects, and immune responses.

Trial Details

NCT Number	NCT07805707
Lead Sponsor	GlaxoSmithKline
Conditions	Influenza, Human
Enrollment	54,000 participants
Start Date	2026-09-02
Primary Completion	2028-06-09 (estimated)
Study Completion	2028-06-09 (estimated)
Updated on ClinicalTrials.gov	2026-09-04